Sreepriya Prasannan
Life Science Journalist & Editor
Sreepriya Prasannan is the Founder and Editor of Priya Life Science, Ireland's independent pharma, biotech and MedTech platform. She holds an MSc in Digital Transformation (Life Science) from Griffith College Dublin, with a background in QA, GMP and production operations. Shortlisted for STEM Graduate of the Year at the Business Post Women in STEM Awards 2026 and a Top 14 finalist in the HSE Spark Ignite 2026 innovation programme, she writes on regulatory trends, GMP compliance and careers across the Irish and European life sciences.
224
Articles
7
Topics
1456
Min Published
Filter:
All 224
Industry 103
Regulatory Affairs 42
Pharmaceutical 30
Biotechnology 16
MedTech 16
LinkedIn 12
Clinical Trials 5
All Articles
Page 1 of 19 — 224 articles
New 
Industry
Budget 2027: €29.1bn for Health, Rare Disease Medicines Pilot
Ireland's Budget 2027 allocates €29.1 billion to health, an increase of €1.76 billion, with a pilot for earlier access to rare disease medicines, a national shingles vaccination programme and more evening and weekend care.
07 Oct 2026
5 min
Industry
Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns
A new EGFSN report says Ireland will need 215,400 digital specialists by 2030 and could be short up to 7,700 a year. It lands as the Citizenship Bill 2026 would raise the residence requirement from five to eight years.
29 Sep 2026
7 min
Industry
Project Management Failures: Lessons for Healthcare
The national children's hospital, now sanctioned at €2.24bn, shows the same project management failures as MetroLink, BusConnects, DART+ and Stuttgart 21. A fact-checked look at the figures, the organisations involved and what healthcare project managers can change.
26 Sep 2026
15 min
Regulatory Affairs
FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli
The FDA approved Onswik (insulin efsitora alfa-gobe), Eli Lilly's once-weekly basal insulin for adults with type 2 diabetes, on 24 September 2026, six months after Novo Nordisk's Awiqli. The trials, the label warning and what it means in Ireland.
25 Sep 2026
6 min
Industry
WeBuild Programme: 50+ Women-Led Ventures and How to Apply
The WeBuild programme has now supported more than 50 women-led tech ventures across the island of Ireland. Eligibility, Cohort 4 dates, how it compares with NextWave and NDRC, and what health founders should know before the 30 October 2026 deadline.
24 Sep 2026
12 min
Pharmaceutical
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity
Astellas Ireland will install a second aseptic filling line at its Kerry Technology Park facility in Tralee, doubling drug-product manufacturing capacity and adding skilled roles by 2029. The 330 million euro plant announced in 2023 is due to open in early 2027.
19 Sep 2026
4 min
Industry
Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing
Irish specialty pharmaceutical company Xeolas Pharmaceuticals officially opens a new 158,000 square foot state-of-the-art facility in Baldoyle, Dublin. The site unifies research, development, formulation, clinical supply, and commercial manufacturing for over 25 pipeline products across 21 countries.
18 Sep 2026
3 min
Industry
Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich
Priya Life Science joins as an official Media Partner for Fleming Events' 9th Annual Corporate Compliance & Transparency in Life Sciences Summit, taking place November 17-18, 2026 in Zurich, Switzerland. Includes an exclusive 20% registration discount code (corporate20) for our readers.
17 Sep 2026
10 min
Industry
AI Will Not Rescue Ireland's Over-Budget Health IT Projects. Pharma-Grade Governance Might.
Ireland is entering a 1.5 to 2 billion euro National Electronic Health Record programme with a poor record on large health IT projects. PPARS and the 2021 cyberattack were governance failures, not technology failures, and AI project tools inherit the optimism they are fed. This analysis argues that the discipline the HSE needs already exists in Irish pharma and MedTech under GAMP 5 and the FDA's Computer Software Assurance guidance.
09 Sep 2026
15 min
Pharmaceutical
Ireland's Eight-Year Citizenship Rule: A Talent-Retention Problem for Pharma, Biotech and MedTech
Ireland built a life-science powerhouse by being the easiest place in Europe for global talent to land and stay. The proposed move from five to eight years for citizenship changes the terms on which the sector's skilled workforce agreed to come here. This analysis looks at what it means for engineers and scientists on Critical Skills permits, for the companies that depend on them, and what a fairer Bill would look like.
07 Sep 2026
8 min
Industry
Jazz Pharmaceuticals Prices Upsized 1.1 Billion Dollar Exchangeable Senior Notes Offering
Jazz Pharmaceuticals has priced an upsized private offering of $1.1 billion in 1.875% exchangeable senior notes due 2032, paired with a concurrent $225 million ordinary share repurchase.
05 Sep 2026
6 min
Industry
AI Governance Is Becoming the Next Major Compliance Test for Life Sciences: Why Irish Leaders Must Benchmark in Zurich
As the EU AI Act, updated EFPIA codes, and multi-jurisdictional enforcement reshape life sciences, the 9th Annual Corporate Compliance & Transparency in Life Sciences Conference in Zurich sets the critical 2027 benchmark for Irish biopharma leaders.
03 Sep 2026
8 min